Skip to content

Tango Therapeutics TNGX Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Exelixis logo
ExelixisEXEL
$11.29B+10.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.25B+816%
CG Oncology logo
CG OncologyCGON
$5.71B+206%

Other financials

Income statement

See full
Revenue--100%
Operating income-$48.8M-14.7%
Net income-$45.5M-14.1%
EPS (diluted)-$0.32+11.1%

Balance sheet

See full
Cash & equivalents$160.0M+162%
Total debt$32.8M-11.3%
Total equity$391.5M+135%
Total assets$435.8M+58.9%

Cash flow

See full
Operating cash flow-$44.4M-6.4%
CapEx-$2.0K-104%
Free cash flow-$44.4M-6.3%

Valuation

See full
Enterprise value$4.43B+2,204%
P/S79.9×+74.4×

Profitability

See full
Operating margin-206.2%-61.0pp
Net margin-188.2%-55.4pp
FCF margin-250.1%-49.4pp

Returns & leverage

See full
Return on equity-38.4%-10.5pp
Debt / equity0.1×-0.1×
Current ratio27.4×+21.1×

Where this comes from

Computed from the period-end share price: $2.99B.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tango Therapeutics's market capitalization?
Tango Therapeutics (TNGX) reported market capitalization of $2.99B in Q1 2026.
How has Tango Therapeutics's market capitalization changed year-over-year?
Tango Therapeutics's market capitalization increased by 1915.5% year-over-year, from $148.11M to $2.99B.
What is the long-term trend for Tango Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Tango Therapeutics's market capitalization has grown at a 3.6% compound annual growth rate (CAGR), from $1B to $1.19B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.